PL207396A1 - Sposob wytwarzania nowych pochodnych kwasu penicylanowego - Google Patents

Sposob wytwarzania nowych pochodnych kwasu penicylanowego

Info

Publication number
PL207396A1
PL207396A1 PL20739678A PL20739678A PL207396A1 PL 207396 A1 PL207396 A1 PL 207396A1 PL 20739678 A PL20739678 A PL 20739678A PL 20739678 A PL20739678 A PL 20739678A PL 207396 A1 PL207396 A1 PL 207396A1
Authority
PL
Poland
Prior art keywords
production
new derivatives
penicylic
acid
penicylic acid
Prior art date
Application number
PL20739678A
Other languages
English (en)
Other versions
PL114501B1 (en
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27122691&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL207396(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer filed Critical Pfizer
Publication of PL207396A1 publication Critical patent/PL207396A1/pl
Publication of PL114501B1 publication Critical patent/PL114501B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PL1978207396A 1977-06-07 1978-06-06 Process for preparing pharmaceutically permissible novel derivatives of penicillanic acid 1,1-dioxide PL114501B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80432077A 1977-06-07 1977-06-07
US87938178A 1978-02-21 1978-02-21

Publications (2)

Publication Number Publication Date
PL207396A1 true PL207396A1 (pl) 1979-06-04
PL114501B1 PL114501B1 (en) 1981-02-28

Family

ID=27122691

Family Applications (1)

Application Number Title Priority Date Filing Date
PL1978207396A PL114501B1 (en) 1977-06-07 1978-06-06 Process for preparing pharmaceutically permissible novel derivatives of penicillanic acid 1,1-dioxide

Country Status (35)

Country Link
AR (1) AR224111A1 (pl)
AT (2) AT360649B (pl)
AU (1) AU513636B2 (pl)
BE (1) BE867859A (pl)
BG (2) BG34614A3 (pl)
CH (1) CH634073A5 (pl)
CS (1) CS208472B2 (pl)
DD (2) DD140888A5 (pl)
DE (2) DE2857263C3 (pl)
DK (1) DK155740C (pl)
EG (1) EG13869A (pl)
FI (1) FI66003C (pl)
FR (2) FR2393804A1 (pl)
GB (1) GB2000138B (pl)
GR (1) GR72255B (pl)
HK (1) HK13184A (pl)
HU (1) HU180042B (pl)
IE (1) IE47079B1 (pl)
IL (2) IL54867A (pl)
IN (1) IN149747B (pl)
IT (1) IT1096381B (pl)
KE (1) KE3355A (pl)
LU (1) LU79774A1 (pl)
MY (1) MY8500092A (pl)
NL (2) NL180009C (pl)
NO (2) NO151746C (pl)
NZ (1) NZ187476A (pl)
OA (1) OA05964A (pl)
PH (3) PH26810A (pl)
PL (1) PL114501B1 (pl)
PT (1) PT68146A (pl)
SE (2) SE436206B (pl)
SG (1) SG65383G (pl)
SU (1) SU860706A1 (pl)
YU (1) YU41829B (pl)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU77306A1 (pl) * 1977-05-09 1979-01-18
DE2912511C2 (de) * 1977-06-07 1982-06-24 Pfizer Inc., 10017 New York, N.Y. Pharmazeutische Zusammensetzung, enthaltend Penicillansäure
DK155942C (da) * 1977-12-23 1989-10-23 Pfizer Analogifremgangsmaade til fremstilling af 6-aminopenicillansyre-1,1-dioxid og fysiologisk acceptable syreadditions- og basesalte deraf.
JPS54126735A (en) * 1978-03-24 1979-10-02 Toyama Chem Co Ltd Bactericidal composition for medical use
US4241050A (en) * 1978-09-01 1980-12-23 Pfizer Inc. Penam 1,1-dioxides as beta-lactamase inhibitors
CA1158639A (en) * 1978-12-11 1983-12-13 Eric M. Gordon 6-bromopenicillanic acid sulfone
IE49881B1 (en) * 1979-02-13 1986-01-08 Leo Pharm Prod Ltd B-lactam intermediates
US4714761A (en) * 1979-03-05 1987-12-22 Pfizer Inc. 6,6-dihalopenicillanic acid 1,1-dioxides and process
US4420426A (en) 1979-03-05 1983-12-13 Pfizer Inc. 6-Alpha-halopenicillanic acid 1,1-dioxides
SE449103B (sv) * 1979-03-05 1987-04-06 Pfizer Sett att framstella penicillansyra-1,1-dioxid samt estrar derav
GB2045236A (en) * 1979-03-26 1980-10-29 Hoechst Uk Ltd Oxapenem derivatives
US4244951A (en) * 1979-05-16 1981-01-13 Pfizer Inc. Bis-esters of methanediol with penicillins and penicillanic acid 1,1-dioxide
US4377524A (en) 1979-05-16 1983-03-22 Pfizer Inc. Bis-esters of methanediol with penicillins and penicillanic acid 1,1-dioxide
US4309347A (en) * 1979-05-16 1982-01-05 Pfizer Inc. Penicillanoyloxymethyl penicillanate 1,1,1',1'-tetraoxide
IE49770B1 (en) * 1979-05-21 1985-12-11 Leo Pharm Prod Ltd 6beta-halopenicillanic acid derivatives
DE3051044C2 (pl) * 1979-06-19 1989-03-30 Leo Pharmaceutical Products Ltd. A/S (Loevens Kemiske Fabrik Produktionsaktieselskab), Ballerup, Dk
US4256733A (en) * 1979-09-26 1981-03-17 Pfizer Inc. Acetoxymethyl penam compounds as β-lactamase inhibitors
US4432970A (en) * 1979-11-23 1984-02-21 Pfizer Inc. 6-beta-Halopenicillanic acid 1,1-dioxides as beta-lactamase inhibitors
IL61880A (en) * 1980-01-21 1984-11-30 Bristol Myers Co 2beta-chloromethyl-2alpha-methylpenam-3alpha-carboxylic acid sulfone derivatives,their preparation and pharmaceutical compositions containing them
US4488994A (en) * 1980-09-08 1984-12-18 Pfizer Inc. Bis-esters of methanediol with penicillins and penicillanic acid 1,1-dioxide
US4432903A (en) * 1980-09-08 1984-02-21 Pfizer Inc. Bis-esters of methanediol with penicillins and penicillanic acid 1,1-dioxide
US4474698A (en) * 1980-12-11 1984-10-02 Pfizer Inc. Process for preparing esters of penicillanic acid sulfone
US4419284A (en) * 1981-03-23 1983-12-06 Pfizer Inc. Preparation of halomethyl esters (and related esters) of penicillanic acid 1,1-dioxide
EP0069962B1 (en) * 1981-07-15 1985-01-02 Kanebo, Ltd. Novel ester of 1,1-dioxopenicillanic acid, process for production thereof, and use thereof as beta-lactamase inhibitor
PT76527B (en) * 1982-04-19 1985-12-09 Gist Brocades Nv A process for the preparation of penicillanic acid 1,1-dioxide and derivatives thereof
US4502988A (en) * 1983-08-08 1985-03-05 Eli Lilly And Company Oxidation process
EP0139047A1 (en) * 1983-10-18 1985-05-02 Gist-Brocades N.V. Process for the preparation of 6,6-dibromopenicillanic acid 1,1-dioxide
US4647457A (en) * 1983-12-16 1987-03-03 Hoffmann-La Roche Inc. Penicillanic acid derivatives
DE3780112T2 (de) * 1986-04-10 1992-12-24 Leo Pharm Prod Ltd Verfahren zur herstellung von penicillansaeure-derivaten.
GB8808701D0 (en) * 1988-04-13 1988-05-18 Erba Carlo Spa Beta-lactam derivatives
CN102977120B (zh) * 2012-12-14 2015-05-27 江西富祥药业股份有限公司 一种舒巴坦匹酯制备及结晶方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3197466A (en) * 1961-10-30 1965-07-27 Smith Kline French Lab Penicillin sulfoxides and process
LU77306A1 (pl) * 1977-05-09 1979-01-18
EP0000636A1 (en) * 1977-07-13 1979-02-07 Glaxo Group Limited Penem compounds, processes for their preparation, their use in pharmaceutical compositions and azetidinones used in their preparation

Also Published As

Publication number Publication date
NO152448B (no) 1985-06-24
SE8305916D0 (sv) 1983-10-27
NL930064I1 (nl) 1993-09-01
DD148585A5 (de) 1981-06-03
DE2857263B2 (de) 1981-04-23
BG34614A3 (bg) 1983-10-15
PT68146A (en) 1978-07-01
GB2000138B (en) 1982-03-03
FI781800A7 (fi) 1978-12-08
HU180042B (en) 1983-01-28
AU3683878A (en) 1979-12-06
GB2000138A (en) 1979-01-04
DD140888A5 (de) 1980-04-02
FR2393804B1 (pl) 1980-11-07
NO781970L (no) 1978-12-08
LU79774A1 (fr) 1980-01-22
AR224111A1 (es) 1981-10-30
NL180009C (nl) 1986-12-16
OA05964A (fr) 1981-06-30
YU41829B (en) 1988-02-29
SE8305916L (sv) 1983-10-27
NO151746C (no) 1985-06-05
CS208472B2 (en) 1981-09-15
CH634073A5 (en) 1983-01-14
IL54867A (en) 1981-11-30
NZ187476A (en) 1982-08-17
YU117078A (en) 1983-01-21
DE2824535B2 (de) 1980-05-14
DK251478A (da) 1978-12-08
NO823126L (no) 1978-12-08
AT360649B (de) 1981-01-26
NO151746B (no) 1985-02-18
PH16465A (en) 1983-10-20
PH26810A (en) 1992-11-05
DE2824535C3 (de) 1981-01-22
MY8500092A (en) 1985-12-31
ATA411278A (de) 1980-06-15
DK155740B (da) 1989-05-08
IL62168A0 (en) 1981-03-31
FR2393805B1 (pl) 1984-02-24
SE7806628L (sv) 1978-12-08
IT7824270A0 (it) 1978-06-06
GR72255B (pl) 1983-10-06
BG34615A3 (bg) 1983-10-15
AU513636B2 (en) 1980-12-11
IT1096381B (it) 1985-08-26
BE867859A (fr) 1978-12-06
PL114501B1 (en) 1981-02-28
IL54867A0 (en) 1978-08-31
FR2393805A1 (fr) 1979-01-05
NL7806126A (nl) 1978-12-11
IE47079B1 (en) 1983-12-14
FI66003C (fi) 1984-08-10
PH21116A (en) 1987-07-16
SG65383G (en) 1985-03-29
IE781140L (en) 1978-12-07
FR2393804A1 (fr) 1979-01-05
EG13869A (en) 1983-03-31
ATA128580A (de) 1981-02-15
SE436206B (sv) 1984-11-19
DK155740C (da) 1989-10-23
SE447995B (sv) 1987-01-12
NL930064I2 (nl) 1994-04-18
DE2857263C3 (de) 1981-12-17
FI66003B (fi) 1984-04-30
AT364084B (de) 1981-09-25
HK13184A (en) 1984-02-24
DE2824535A1 (de) 1978-12-14
KE3355A (en) 1983-12-16
SU860706A1 (ru) 1981-08-30
IN149747B (pl) 1982-04-03
NO152448C (no) 1985-10-02

Similar Documents

Publication Publication Date Title
PL207396A1 (pl) Sposob wytwarzania nowych pochodnych kwasu penicylanowego
PL207337A1 (pl) Sposob wytwarzania pochodnych ftalazyny
PL195997A1 (pl) Sposob wytwarzania nowych pochodnych karboksyalkiloacyloaminokwasow
PL196886A1 (pl) Sposob wytwarzania nowych alkilooksymow pochodnych kwasu 7-amino-tiazolilo-acetamido-cefalosporynowego
PL195504A1 (pl) Sposob wytwarzania nowych oksymow pochodnych kwasu 7-amino-tiazolilo-acetamido-cefalosporanowego
IT1094843B (it) Metodo di produzione di d-alfa-amminoacidi
PL205895A1 (pl) Sposob wytwarzania estrow kwasu szczawiowego
PL191647A1 (pl) Sposob wytwarzania pochodnych tienopirydyny
PL204616A1 (pl) Sposob wytwarzania pochodnych 1-oksadetiacefamowych
PL205592A1 (pl) Sposob wytwarzania nitrozobenzenu
PL197704A1 (pl) Sposob wytwarzania nowych pochodnych indazoliloksy 4-propanoloaminy
PL208318A1 (pl) Sposob wytwarzania pochodnych tienopirydyny
PL209256A1 (pl) Sposob wytwarzania pochodnych kwasu 2-hydrazonopropionowego
PL204551A1 (pl) Sposob wytwarzania nowych pochodnych kwasu benzoheterocykloglioksalowego
SE7804261L (sv) Forfarande for framstellning av prostansyraderivat
PL204428A1 (pl) Sposob wytwarzania nowych pochodnych erytomycyny
PL204212A1 (pl) Sposob wytwarzania pochodnych p-nitrozodwufenylohydroksyloaminy
PL204590A1 (pl) Sposob wytwarzania pochodnych kwasu 2-metylo-2-fenoksypropionowego
PL204065A1 (pl) Sposob wytwarzania nowych pochodnych kwasu amino-cykloalkanopenamokarboksylowego
PL205586A1 (pl) Sposob wytwarzania pochodnych kwasu oksazolinoazetydynylopentenylowego
PL210157A1 (pl) Sposob wytwarzania nowych pochodnych kwasow aryloalkanokarboksylowych
PL210683A1 (pl) Sposob wytwarzania kwasu 2,5-dwuketoglikonowego
PL204553A1 (pl) Sposob wytwarzania nowych pochodnych kwasu inolilogliksalowego
SE7810526L (sv) Forfarande for framstellning av klorvetesyra
PL200062A1 (pl) Sposob wytwarzania pochodnych kwasu alfa-arylopropionowego